Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

1.

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.

Siegel R, Ward E, Brawley O, Jemal A.

CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121. Epub 2011 Jun 17.

PMID:
21685461
[PubMed - indexed for MEDLINE]
Free Article
2.

Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.

Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, Tang L, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, Lippman SM, Thompson IM, Ambrosone CB, Hoque A.

Cancer Causes Control. 2011 Aug;22(8):1121-31. doi: 10.1007/s10552-011-9787-7. Epub 2011 Jun 11.

PMID:
21667068
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men.

Karatzas A, Giannatou E, Tzortzis V, Gravas S, Aravantinos E, Moutzouris G, Melekos M, Tsezou A.

Cancer Epidemiol. 2010 Jun;34(3):345-9. doi: 10.1016/j.canep.2010.02.009. Epub 2010 Mar 21.

PMID:
20308029
[PubMed - indexed for MEDLINE]
4.

The presence of the CYP11A1 (TTTTA)6 allele increases the risk of biochemical relapse in organ confined and low-grade prostate cancer.

Celhar T, Gersak K, Ovcak Z, Sedmak B, Mlinaric-Rascan I.

Cancer Genet Cytogenet. 2008 Nov;187(1):28-33. doi: 10.1016/j.cancergencyto.2008.08.003.

PMID:
18992638
[PubMed - indexed for MEDLINE]
5.

Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Kristal AR, Schenk JM, Song Y, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.

Am J Epidemiol. 2008 Dec 15;168(12):1416-24. doi: 10.1093/aje/kwn272. Epub 2008 Oct 21.

PMID:
18945688
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Frequencies of promoter pentanucleotide (TTTTA)n of CYP11A gene in European and North African populations.

Piras I, Falchi A, Moral P, Melis A, Giovannoni L, Paoli G, Calò C, Vona G, Varesi L.

Genet Test. 2008 Mar;12(1):93-6. doi: 10.1089/gte.2007.0060.

PMID:
18307388
[PubMed - indexed for MEDLINE]
7.

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.

Endogenous Hormones and Prostate Cancer Collaborative Group, Roddam AW, Allen NE, Appleby P, Key TJ.

J Natl Cancer Inst. 2008 Feb 6;100(3):170-83. doi: 10.1093/jnci/djm323. Epub 2008 Jan 29.

PMID:
18230794
[PubMed - indexed for MEDLINE]
Free Article
8.

Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.

Cussenot O, Azzouzi AR, Nicolaiew N, Fromont G, Mangin P, Cormier L, Fournier G, Valeri A, Larre S, Thibault F, Giordanella JP, Pouchard M, Zheng Y, Hamdy FC, Cox A, Cancel-Tassin G.

J Clin Oncol. 2007 Aug 20;25(24):3596-602.

PMID:
17704407
[PubMed - indexed for MEDLINE]
9.

Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer.

Cunningham JM, Hebbring SJ, McDonnell SK, Cicek MS, Christensen GB, Wang L, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):969-78.

PMID:
17507624
[PubMed - indexed for MEDLINE]
Free Article
10.

Enhanced induction of prostatic dysplasia and carcinoma in Noble rat model by combination of neonatal estrogen exposure and hormonal treatments at adulthood.

Yuen MT, Leung LK, Wang J, Wong YC, Chan FL.

Int J Oncol. 2005 Dec;27(6):1685-95.

PMID:
16273225
[PubMed - indexed for MEDLINE]
11.

Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11alpha in prostate cancer risk and aggressiveness.

Cicek MS, Liu X, Casey G, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2173-7.

PMID:
16172228
[PubMed - indexed for MEDLINE]
Free Article
12.

Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta.

Douglas JA, Zuhlke KA, Beebe-Dimmer J, Levin AM, Gruber SB, Wood DP, Cooney KA.

Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):2035-9.

PMID:
16103457
[PubMed - indexed for MEDLINE]
Free Article
13.

Androgen deprivation therapy for prostate cancer.

Sharifi N, Gulley JL, Dahut WL.

JAMA. 2005 Jul 13;294(2):238-44. Review.

PMID:
16014598
[PubMed - indexed for MEDLINE]
14.

No association between a tetranucleotide repeat polymorphism of CYP19 and prostate cancer.

Li L, Cicek MS, Casey G, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2280-1. No abstract available.

PMID:
15598794
[PubMed - indexed for MEDLINE]
Free Article
15.

Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.

Payne AH, Hales DB.

Endocr Rev. 2004 Dec;25(6):947-70. Review.

PMID:
15583024
[PubMed - indexed for MEDLINE]
16.

Estrogen metabolites, conjugates, and DNA adducts: possible biomarkers for risk of breast, prostate, and other human cancers.

Rogan EG, Cavalieri EL.

Adv Clin Chem. 2004;38:135-49. Review. No abstract available.

PMID:
15521191
[PubMed - indexed for MEDLINE]
17.

Human prostate cancer risk factors.

Bostwick DG, Burke HB, Djakiew D, Euling S, Ho SM, Landolph J, Morrison H, Sonawane B, Shifflett T, Waters DJ, Timms B.

Cancer. 2004 Nov 15;101(10 Suppl):2371-490. Review.

PMID:
15495199
[PubMed - indexed for MEDLINE]
Free Article
18.

A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism.

Gennari L, Masi L, Merlotti D, Picariello L, Falchetti A, Tanini A, Mavilia C, Del Monte F, Gonnelli S, Lucani B, Gennari C, Brandi ML.

J Clin Endocrinol Metab. 2004 Jun;89(6):2803-10.

PMID:
15181061
[PubMed - indexed for MEDLINE]
19.

Local aromatase expression in human prostate is altered in malignancy.

Ellem SJ, Schmitt JF, Pedersen JS, Frydenberg M, Risbridger GP.

J Clin Endocrinol Metab. 2004 May;89(5):2434-41.

PMID:
15126575
[PubMed - indexed for MEDLINE]
20.

Microsatellite polymorphism of steroid hormone synthesis gene CYP11A1 is associated with advanced prostate cancer.

Kumazawa T, Tsuchiya N, Wang L, Sato K, Kamoto T, Ogawa O, Nakamura A, Kato T, Habuchi T.

Int J Cancer. 2004 May 20;110(1):140-4.

PMID:
15054879
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk